Federal health advisers have ruled that a drug intended to prevent premature births doesn’t work, clearing the way U.S. regulators to follow through on a long-delayed effort to get it off the market.
The Food and Drug Administration’s advisory panel voted 14-1 that the injectable drug Makena should be removed from the market, despite appeals from the manufacturer to keep it available pending additional research.
